Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer

Han Guan1, Rui Peng1, Fang Fang2

  • 1Department of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, China.

Insights

Tumor-associated macrophages release exosomes containing miR-95, which promotes prostate cancer (PCa) cell growth and invasion. Targeting this miR-95/JunB pathway may offer new PCa therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor-associated macrophages (TAMs) play a key role in the tumor microenvironment.
  • The molecular mechanisms of TAM-tumor cell interactions are not fully understood.
  • Exosomes derived from TAMs are implicated in regulating tumor progression.

Purpose of the Study:

  • To investigate the role of TAM-derived exosomes in prostate cancer (PCa) progression.
  • To identify specific molecular components within these exosomes that influence PCa.
  • To explore the therapeutic potential of targeting TAM-exosome communication in PCa.

Main Methods:

  • Analysis of microRNA sequences in exosomes from THP-1 and M2 macrophages.
  • In vitro and in vivo loss-of-function assays to study miR-95 effects on PCa cells.
  • Investigation of the downstream target gene (JunB) of miR-95.
  • Correlation analysis of miR-95 expression with clinicopathological features in PCa patients.

Main Results:

  • TAM-derived exosomes showed significantly increased levels of miR-95.
  • PCa cells directly uptake miR-95 from these exosomes.
  • miR-95 promotes PCa cell proliferation, invasion, and epithelial-mesenchymal transition by targeting JunB.
  • Higher miR-95 expression correlated with worse clinicopathological features in PCa.

Conclusions:

  • TAM-mediated PCa progression is partly driven by miR-95 in TAM-derived exosomes.
  • The miR-95/JunB axis is a key mechanism in PCa development.
  • This finding provides a basis for developing personalized therapies targeting TAMs for PCa treatment.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K